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ABSTRACT 
 
BACKGROUND  
Pneumonia is the leading cause of mortality in under five children. 
Studies show zinc deficiency is associated with pneumonia. 
OBJECTIVE  
We aimed to study the relationship between the serum zinc level 
and severe pneumonia. 
PATIENTS AND METHODS  
A case control study was conducted at the Coimbatore medical 
college, in the Pediatric department in 6 to 60 months old children. Fifty 
children with severe pneumonia and fifty children as controls matched 
with age, sex and nutrition were included. 
RESULTS 
80 percent of children with severe pneumonia had low serum zinc 
levels while 20 percent of controls only had low serum zinc levels. 
 
CONCLUSION  
We concluded that severe pneumonia is associated with lower 
serum zinc level and lower the serum zinc levels the higher the 
respiratory distress and lower the oxygen saturation. However large scale 
studies are needed in this field. 
KEY WORDS 
                       ZINC, CHILDREN, PNEUMONIA  
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INTRODUCTION 
 
Pneumonia is one of the main causes of death in under five 
children.  There are many studies which show that zinc deficiency is 
associated and may lead to the cause of pneumonia. In our region we 
have no data about serum zinc levels in under five children and in the 
hospitalised children with pneumonia. So this study aims to find them. 
This may give us an idea about necessary for zinc supplementation in 
under five children and also the need for serum zinc level estimation in 
children with severe pneumonia as a routine investigation in pneumonia 
management.   
The WHO 2014 November report says that “pneumonia is the 
leading infectious cause of death in children worldwide, accounting for 
15% of all deaths of children under 5 years old. 
 Pneumonia killed an estimated 935 000 children under the age of 
five in 2013.Pneumonia can be caused by viruses, bacteria or fungi 
pneumonia can be prevented by immunization, adequate nutrition and by 
addressing environmental factors. 
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Pneumonia caused by bacteria can be treated with antibiotics, but 
only one third of children with pneumonia receive the antibiotics they 
need 
Pneumonia is a form of acute respiratory infection that affects 
the lungs. The lungs are made up of small sacs called alveoli, which 
fill with air when a healthy person breathes. When an individual has 
pneumonia, the alveoli are filled with pus and fluid, which makes 
breathing painful and limits oxygen intake. 
Pneumonia is the single largest infectious cause of death in 
children worldwide. Pneumonia killed an estimated 935 000 children 
under the age of five in 2013, accounting for 15% of all deaths of 
children under five years old. Pneumonia affects children and families 
everywhere, but is most prevalent in South Asia and sub-Saharan 
Africa. Children can be protected from pneumonia, it can be prevented 
with simple interventions, and treated with low-cost, low-tech 
medication and care Zinc is an essential trace element required for 
maintaining intestinal cells, bone growth, and immune function. 
Children who are living in low-income settings are often 
undernourished and zinc deficient. Severe zinc deficiency has been 
 associated with stunting of growth, impaired immunity, skin di
learning disabilities and anorexia
“Studies of zinc supplementation for the treatment or improved 
management of acute lower respiratory tract infections, including 
pneumonia have had mixed results. 
combination with oral r
basis of the WHO/UNICEF recommendation for use in the 
management of children with diarrhoea.
CAUSES OF ZINC DEFICIENCY
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”. 
Zinc supplementation in 
ehydration solution has already formed the 
” 
 
sorders, 
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Though the zinc deficiency occurs due to various reasons, the need 
to correct is important as many studies show higher death rate with 
children affected with pneumonia is associated with low level of zinc. 
   It is obvious if we have data regarding prevalence of zinc 
deficiency it will be useful to treat that. Also the zinc content in soil is not 
the same throughout the world .so many factors are involved in zinc 
deficiency and its relevance with various diseases. The second most 
important among them is pneumonia. 
The WHO has devised a multifactorial approach in management of 
pneumonia now for effective treatment zinc supplementation is also 
suggested. But deficiency status is essential for treatment of pneumonia, 
since only then adequate dose of zinc therapy can be instituted. 
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This picture shows that our country also comes  in the area of wide 
spread zinc deficiency. 
 There are various studies supporting zinc supplementation in zinc 
deficient population which given in adequate doses prevents pneumonia. 
Also mortality associated with pneumonia can also be reduced by this 
effort.  
There is no study detailing the level of zinc deficiency and  severe 
pneumonia in our region.  
This study aims at finding out the correlation between level of zinc 
with severe pneumonia.  
This study might throw a light on need for prophylactic zinc 
supplementation in under five children and the need to estimate serum 
zinc level in children with pneumonia as a routine. 
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AIM OF THE STUDY 
 
Aim of the study is to compare the serum zinc levels among 
children 6 months to 60 months of age hospitalised with severe 
pneumonia with the same age matched controls.  
OBJECTIVE OF THE STUDY 
1. To find serum zinc level in the hospitalised children 6 to 60 months 
of age with severe pneumonia  
2. To find serum zinc levels in the age matched controls  
3. To find the relationship between the serum zinc level and  severe  
pneumonia 
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MATERIALS AND METHODS 
 
 Patients 6 to 60 months admitted with severe pneumonia (both 
bronchopneumonia and lobar pneumonia)  as  per WHO criteria, 
with x-ray finding  are selected. Serum  zinc levels are estimated in 
them. 
  Then age, sex and nutrition matched controls are selected from 
outpatient department and their serum zinc levels are estimated. 
Then the relationship between serum zinc levels and severe pneumonia is 
studied. 
INCLUSION CRITERIA FOR CASES: 
 All hospitalized  children 6 to 60 months of age with severe 
pneumonia as per WHO criteria, with x-ray changes(Both 
bronchopneumonia and lobar pneumonia) 
EXCLUSION CRITERIA 
 1. Children with clinical features of congenital zinc deficiency  
 2. Patients with PEM grade III and IV (IAP classification)  
 3. Patients with clinical features suggestive of immunodeficiency.  
 4. Patients with acute diarrhoeal diseases.  
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 5. Patients with hospital acquired pneumonia.  
 6. Children taking zinc containing supplements.  
Inclusion criteria for controls 
 Age matched healthy controls  
Exclusion criteria for controls 
 Children with clinical features of congenital zinc deficiency  
 Children with PEM grade III and IV (IAP classification)  
 Children taking zinc containing supplements  
STUDY DESIGN 
“This is a case control study conducted at the department of 
paediatrics, Coimbatore Medical College Hospital from July 2014- 
June2015”.  
Method of collection of data 
 Sample size:   
  Minimum of 50 cases and 50 controls are included for study.  
Sample size calculation formula 
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Sample Size Calculation  formula 
 “ n= t² x p (1-p) / m² 
 Description: 
n = required sample size 
T = confidence level of 95% 
p = Expected Frequency of the Factor under Study  – 1.6% 
M = margin of error of 5% 
 (Standard value of 0.05) 
n = 97” 
 Contingency 
    “The sample is further increased by 5% to account for contingencies 
such as non-response or recording error. 
 n + 5% = 97 x 5% = 100 [BOTH GROUPS] 
  EACH GROUP - 50+ 50  
CASE - 50 nos 
CONTROL - 50 nos” 
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STUDY PROCEDURE 
 All children included in this study are from lower socioeconomic 
class as per modified kuppusamy scale. 
 Prior consent is obtained from parents of the children included in 
this study. 
 Admitted patients included in the study are evaluated by taking 
detailed history as per the proforma attached. 
  Blood sample is taken from them. 
  Serum zinc levels are estimated using atomic absorption 
spectrometry. 
 Their course in the hospital, duration of stay and their outcomes are 
noted.  
 Age matched controls for the cases are selected from the paediatric 
outpatient department.  
 Blood from them is tested for serum zinc levels by the same 
method.  
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Zinc estimation 
For estimation of zinc 2 ml of blood  collected using 22 gauge steel 
needle in a dry tube and allowed to be clotted and serum separates and 
then sent for processing or stored in 2 to 8 degree in refrigerator for 
maximum of 48 hours and sent to private lab for processing. The serum 
zinc level is estimated using Atomic absorption spectrometer. 
Serum Zinc level – “cut off values” 
 “For males and females less than 10 years in south asian 
population is 65µg/dL. 
Reference : Saeed Akhtar.Zinc status in south asian populations – 
an update.J Health popul nutr 2013 June;31(2):139-149”. 
Statistical analysis 
“The qualitative variables as expressed in frequency and 
percentage. 
A Chi Square test was used to assess differences in categoric 
variables between groups 
Odds ratio was used to assess the variables. 
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A  p value of <0.05 using a two tailed test was taken as being of 
significance for all statistical tests. 
All data were analysed  with a statistical software package(SPSS, 
version 16.0 for windows)” 
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REVIEW OF THE LITERATURE 
 
Pneumonia defined as inflammation of the lung parenchyma, is the 
leading cause of death globally among children younger than age 5 yr, 
accounting for an estimated 1.2 million (18% total) deaths annually. The 
incidence of pneumonia 10 times more, and the childhood mortality due 
to this disease is two thousand times more. In the world three fourths of 
the deaths from pneumonia occurs in fifteen countries. 
World scenario: throught the world the mortality from pneumonia 
is declined ny ninety seven percent. In 2007 , pneumonia accounted for 
2% of  all the deaths of children less than 5 years of age, than 9% at 1970. 
The reduction in the incidcence is mainly due to the invention of the 
newer antibiotics , good medical care and the  vaccines. 
Once the bacteria Haemophilus influenzae type b was the frequent 
aetology for the bacterial pneumonia in the young children .but after the 
use of the effective vaccine for this there is significant reduction of this 
disease.the measles vaccine reduced significant amount of deaths due to 
post measles pneumnia.the infrastructure in the rural and the remotes 
areas of the developing countries were improved and the access to the 
medical facilities were better in the developing countries like india.the 
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role of the two important vaccine like the pneumococcal conjucate 
vaccine and the flu vaccine is very important in reducing  the pneumonia 
related deaths in the past years.. 
ETIOLOGY 
Pneumonia is mainly caused by infectious agents. But other causes 
also there. 
 In many patients the cause of the pneumonia is very difficult to 
determine as it needs culture of the lung parenchyma which is very 
difficult to perform and also unnecessary in most of the occasions. the 
sputum samples and the samples obtained from the upper respiratory tract 
cant help to accurately find the infectious etiology. The modern 
molecular diagnostic methods help to find the etiological agent whether it 
is a bacteria or virus in the children with community acquired pneumonia. 
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AETIOLOGY  
Infectious causes 
viruses 
Common 
• Respiratory syncytial virus 
•  Parainfluenza types 1-3 
•  Influenzas A, B   
• Adenovirus 
• Human metapneumovirus 
Uncommon 
• Rhinovirus 
• Enterovirus 
• Herpes simplex  
• Cytomegalovirus 
• Measles  
• Varicella  
• Hantavirus 
• Coronavirus 
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 Severe acute respiratory syndrome (SARS),  
Middle East respiratory syndrome [MERS] 
 
BACTERIAL CAUSES 
Common agents 
• Streptococcus pneumonia 
• H. influenzae type b  
• Staphylococcus aureus 
• Moraxellacatarrhalis 
• Neisseriameningitidis 
• Francisellatularensis 
• Nocardia species  
• Chlamydophila psittaci 
• Yersinia pestis 
• Legionella species 
• Coxiella burnetii 
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FUNGAL INFECTIONS 
• Histoplasma capsulatum 
• Blastomyces dermatitidis 
• Coccidioidesimmitis 
• Cryptococcus neoformans 
• Aspergillus species 
• Mucormycosis 
• Pneumocystis jiroveci 
PARASITIC 
• Ascaris 
• Strongyloides species 
The commonest cause of pneumonia in children less than four 
years is Streptococcus pneumonia. Mycoplasma pneumoniae and 
Chlamydophila pneumoniae are the most frequent bacterial pathogens in 
children age five years  and above. In addition to pneumococcus the other 
bacterial causes of pneumonia in previously healthy children are group A 
streptococcus also known as Streptococcus pyogenes and Staphylococcus 
aureus. Staphylococcus aureus pneumonia is the common complication of 
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the influenza virus infection. The commonest infection causing morbidity 
and mortality in children of the developing countries are 
1. Streptococcus pneumoniae  
2. Hemophilous influenza 
3. Staphylococcus aureus  
4. In HIV infected patients - Mycobacterium tuberculosis, atypical 
mycobacteria Salmonella , Escherichia coli  and Pneumocystis  
jiroveci 
Aetiology of the causative organism based on the age 
Age group Causative organism 
 Birth to three weeks 
 Streptococci group B, E. coli 
 Haemophilus influenza type b and non typeable 
3 weeks to 3 months Respiratory syncytial virus;  rhinoviruses ;  para 
influenzaviruses  influenzaviruses   adenovirus    
S. pneumoniae H. influenzae type b and 
nontypeable Chlamydia trachomatis in afebrile 
patients. 
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4 months to 4years   “Respiratory syncytial virus rhinoviruses  
influenza viruses adenovirus S. pneumoniae    
H. influenzae type b Mycoplasma pneumoniae 
group A streptococcus” 
More than five years “M.pneumoniae,S. pneumoniae, Chlamydophila 
pneumoniae, H. influenzae type b and 
nontypeable influenza viruses adenovirus other 
respiratory viruses Legionella pneumophila” 
In the areas where routine immunization is implemented for 
H.influenzae and Pneumococci there is a reduction in the incidence of 
pneumonia noted. 
Viruses are the most common organism responsible for the  lower 
respiratory tract infections in infants and children above one month but 
below fiveyear of age. By using molecular diagnostic methods Viruses 
can be found in more than half  of children with pneumonia. Among  the 
respiratory viruses the respiratory syncytial virus  and rhinoviruses are the 
most commonly identified mainly in children less than two year of age. 
However as the rhino viruses are often detected in asymptomatic children 
the role of rhinoviruses in severe lower respiratory tract infection remains 
poorly defined. Other common viruses causing pneumonia include 
influenza virus, adeno viruses parainfluenza viruses and enteroviruses 
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and human metapneumovirus. In about 20% of the patients with 
pneumonia more than one virus are isolated.In both the hemespheres of 
the earth the “lower respiratory tract infections are more common in the 
fall and winter in relation to the seasonal epidemics of respiratory viral 
infection that may  occur each and every year. At the beginning of thee 
fall para influenza infections typically appear and most commonly start as 
croup. After that in winter Respiratory syncytial virus, human meta 
pneumovirus and then influenza viruses may cause upper respiratory tract 
infections and widespread infections including bronchiolitis and 
pneumonia. Respiratory syncytial virus is particularly very severe among 
infants and young children. But unlike that influenza virus causes more 
morbidity in the form of disease and excess hospital admissions for acute 
respiratory problems  in all age groups”.  
Immunization status should be known as children fully vaccinated  
against H. influenzae type b and Streptococcus pneumoniae are less likely 
to be infected with the above organisms. “Immune compromised children 
and those who have an underlying illness may be at risk for infection with 
specific pathogens. such as In patients with cystic fibrosis Pseudomonos 
species are the commonest organism causing lower respiratory tract 
infection”. 
  
 PATHOGENESIS
This is the mechanism of protection of our respiratory tract.
This is the mechanism of pathogenesis of viral pneumonia.
 
VIRAL PNEUMONIA
DIRECT
INJURY
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AIRWAY
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SECONDARY
BACTERIAL
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MORPHOLOGY  
Bacterial pneumonias  have two types  of anatomic distribution. 
One is lobular broncho pneumonia and the other is lobar pneumonia. 
In broncho pneumonia there is “patchy consolidation of the lung which 
is  the dominant feature”. But in lobar pneumonia it is the  consolidation  
of  a large  portion  of  a  lobe  and or of  an  entire  lobe  defines  
lobar  pneumonia.  But in practice these  anatomic  categorizations  
may  be difficult  to  apply because  patterns  overlap.when the 
infection progresses the  patchy  involvement  may  become  
confluent. This produces  almost  total  lobar  consolidation.  but with 
a highly effective  antibiotic therapy that may limit  involvement  to  a  
subtotal  consolidation.sometimes the  same  organisms  may  produce  
any one of the two patterns depends on the susceptibility of the different 
patiens.the important  thing in  clinical  standpoint  are the  identification  
of  the  bacteria which is causing the disease and to determine the extent 
of the disease.  
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Lobar  pneumonia 
  Classically there are four  stages  of  the  inflammatory response  
1. Congestion 
2. red hepatization 
3. gray  hepatisation 
4. resolution.   
In the first stage, that is the stage of congestion the lungs  are 
heavy, boggy, and red.  This phase is characterized by engorgement of 
the vascular compartment and intra alveolar liquid with some 
neutrophils. Numerous bacteria were also present at this stage. In the next 
stage  of  red  hepatization is  characterized  by massive  confluent  
exudation. This is happen as  neutrophils , red cells and  fibrin fill  the  
alveolar  spaces. On examination  the lobe  is  red  firm  and  may 
have no air. It may have  a  liver like  consistency. Because of that it is 
called as hepatization.  The  next stage that follows is   of  gray  
hepatisation.this stage  is  marked  by  progressive  disintegration  of  
red  cells. Also there is the  persistence  of  a  fibrinosuppurative  
exudate and it undergoes  organization. This may leave  fibrous  
thickening  or  permanent  adhesions.the lesions  of  broncho 
pneumonia  are  consolidated  areas  of  acute suppurative  
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inflammation.  this  may  be  confined to  one  lobe. Sometime it is 
more  often  multi lobar. Some times it is   frequently  bilateral and  
basal  because  of  the  tendency  of  secretions  to  gravitate  to the  
lower  lobes.  Well developed  lesions  are  slightly  elevated and dry 
and granular. They are also gray red  to  yellow  and  poorly  
delimited  at  their margins.  Histologically  the  reaction  usually  
elicits  a neutrophil rich  exudate  that  fills  the  bronchi  bronchioles  
and adjacent  alveolar  spaces. Pleural  fibrinous  reaction  to  the  
underlying  inflammation,  often present in the early stages if the 
consolidation extends to the  surface and may resolve.The 
complications  of  pneumonia  are 
1) tissue  destruction and  necrosis,  causing  abscess  
formation.these complications are very common  with 
pneumococci type 3 and   Klebsiella  
2) spread  of  infection  to  the  pleural  cavity and that may lead 
to the  intra pleural  fibrino suppurative  reaction  known. This 
is known as empyema 
3) dissemination of the bacteria through the blood to the heart valves  
pericardium  brain  kidneys  spleen  and  joints. This spread 
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may cause metastatic abscesses,  endocarditis,  meningitis and  
suppurative  arthritis. 
RECURRENTPNEUMONIA 
The definition of the recurrent pneumonia is 
• 2 or more episodes in a single year or  
• 3 or more episodes ever 
There should be clearance of the radiological lesions inbetween the 
episodes.  
CLINICAL MANIFESTATIONS 
Pneumonia is frequently starts with non specific repiratory 
symptoms .  
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DIAGNOSIS 
The diagnosis needs the presence of an infiltrate on chest Xray. 
The Xray may also detect the complications of the pneumonia .The 
characteristic feature of the viral pneumonia usually is hyperinflation 
with bilateral interstitial infiltrates and peri bronchial cuffing. 
Pneumococcal pneumonia is typically associated with confluent lobar 
consolidation. “The radiographic features alone are not diagnostic.The 
other clinical features also should be considered for the diagnosis . In the 
patients with uncomplicated pneumonia Repeat chest radiographs are not 
required for proof of cure. Many experts advised that a chest radiograph 
may not be necessary for older children with suspected pneumonia. 
cough, fever, localized crackles, or decreased breath sounds who are well 
enough to be managed as outpatients.  
The use of portable or handheld ultrasonography is highly sensitive 
and specific for the  diagnosis of the pneumonia in children. This is by 
findins consolidations of the lung and air bronchograms or  pleural 
effusions. 
The differentiation from viral and bacterial pneumonia can be 
made by total leucocyte counts.The total leucocyte count can be normal 
or elevated in viral pneumonia. But it is usually less than 20,000. There 
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may be a lymphocyte predominant picture.  In bacterial pneumonia there 
is a very high total leucocyte count. This is usually in the range of 
15,000- 40,000/mm3. There is a predominant granulocytes.  The bacterial 
etiological cause is suggested by the presence of a large pleural effusion 
and lobar consolidation. There may be a high fever at the onset of the 
illness. Atypical pneumonia caused by Chlamydia  pneumoniae or 
Mycoplasma pneumoniae is difficult to differentiate from pneumococcal 
pneumonia  based on the radiographic and laboratory findings. Although 
pneumococcal pneumonia is associated with a higher total leucocyte 
count, erythrocyte sedimentation rate, procalcitonin, and C-reactive 
protein level. There is considerable overlap especially with adenoviruses 
and enteroviruses”. 
In the viral infections the gold standard confirmative investigations 
are  
• the isolation of a virus or  
• detection of the viral genome or  
• antigen in respiratory tract secretions.  
For the rapid detection of many respiratory micro organisms such 
as Mycoplasma Pertussis, and many viruses including Respiratory 
syncytial viruses parainfluenza viruses influenza viruses and 
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adenoviruses there are many reliable and accurate deoxyribo nucleic acid 
or ribonucleic acid tests available.  
“Serologic techniques can also be used to diagnose a recent 
respiratory viral infection.but they usually require testing of acute and 
convalescent serum samples.In those samples there may be a rise in 
antibodies to a specific viral agent. This diagnostic technique is laborious 
and slow.Also they are clinically not very useful. By the time it is 
confirmed serologically the infection usually resolves.  
Serologic testing may be valuable as an epidemiologic tool to 
estimate the incidence and prevalence of the many types of respiratory 
tract viral micro organisms. Determination of the peripheral cell gene 
expression pattern by microarray reverse transcription polymerase chain 
reaction is an emerging technology. This technique may help to 
differentiate viral pneumonia from bacterial causes of pneumonia. 
The gold standard and the definitive diagnosis of a bacterial 
infection needs isolation of an organism from the blood or the pleural 
fluid or from the lung. Sputum culture is not of significant  value in the 
diagnosis of pneumonia in very young children. 
The  percutaneous aspiration of the lung is invasive. Also it is not  
routinely performed. Blood culture results are positive  only  in ten 
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percent of children the with pneumococcal pneumonia”. Blood cultures 
were not recommended routinely for non toxic appearing children treated 
as an outpatient. Blood cultures are only recommended for those who fail 
to improve and  have clinical deterioration and in those with complicated 
pneumonia . also blood culure is recommended for  those requiring 
hospital admission.  
Cold agglutinins in a titers more than 1: 64 are detected in the 
serum in about fifty percent of patients with Mycoplasma pneumoniae 
infections. Cold agglutinin titers were nonspecific. The other pathogenic 
organisms such as influenza viruses may also cause elevated cold 
agglutinin titres.  
Acute infection caused by M. pneumoniae can be diagnosed on the 
basis of the following 
1. a positive polymerase chain reaction test result or  
2. seroconversion in an IgG assay.  
For the diagnosis of the group A streptococcal pneumonia 
serologic evidence like the anti streptolysin O titer (ASO)  may be very 
useful . 
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Indications for admission in the hospital in Children with Pneumonia 
• less than six month of age 
• Sickle cell disease with features of acute chest syndrome 
• Involvement of multiple lobes of the lung 
• Immuno deficiency state 
• Toxic appearance 
•  Complicated pneumonia 
 Pleural effusion 
 Empyema 
 acute respiratory distress syndrome 
 extrapulmonary infection like central nervous system 
infection, pericarditis,endocarditis and osteomyelitis 
 hemolytic uremic syndrome 
  sepsis 
• “Moderate to severe respiratory distress 
• Requirement oxygen supplement  
• Dehydration 
• Vomiting or inability to tolerate oral fluids or medications 
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• No response to appropriate oral antibiotic therapy 
• Social factors”  
TREATMENT 
Treatment of presumed bacterial pneumonia is based on the 
suspected cause and the age and clinical appearance of the child. 
Amoycillin is the recommended medicine for the less toxic children in 
whom there desnt need hospital admission. As there is emerging increase 
in the strains of penicillin resistance high doses of amoxicillin ie 80 to 90 
mgper  kilogram per day should be prescribed. The other alternative 
medications are include Cefuroxime axetil and amoxicillin clavulanic 
acid.  
An antibiotic like Azithromycin or Clarithromycin is recommended for 
• School age children and  
• in children in whom infection with Mycoplasma pneumoniae and 
Chylamydia pneumoniae is. 
The broad spectram respiratory quinol;ones like levofloxacin or 
moxifloxacin are considered as an alternatives in adolescents.in the 
developing countries there are many factors which prevent the medical 
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management. There only about sixty percent of children with symptoms 
of pneumonia were taken to an appropriate caregiver. And among them 
only less than 1/3 only receive appropriate antibiotics.  
“The World Health Organization and other international groups 
have developed systems.this system  train the mothers and local area 
healthcare providers in the recognition and treat- ment of pneumonia. In 
India it is called as IMNCI guidelines which is followed in the local 
health care system”. 
The empirical treatment of suspected bacterial pneumonia 
Ampicillin or penicillin G  
• in areas without substantial high-level penicillin resistance among 
S. pneumoniae,  
• children who are fully immunized against H. influenzae type b and 
S. pneumonia 
• who are not severely ill  
ceftriaxone or cefotaxime 
• for children who do not meet these criteria 
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Vancomycin or Clindamycin 
• if clinical features suggest staphylococcal pneumonia like 
pneumatoceles or empyema 
No antibiotics 
• If viral pneumonia is suspected especially for those patients who 
are mildly ill 
• are in no respiratory distress. 
However “about thirty percent of patients with known viral 
infection especially influenza viruses may have coexisting bacterial 
pathogens. Hence if the decision is made to withhold antibiotic therapy 
on the basis of presumptive diagnosis of a viral infection, deterioration in 
clinical status should signal the possibility of superimposed bacterial 
infection”. In the above clinical situation antibiotic therapy should be 
initiated. 
Duration of antibiotics 
The “optimal and exact duration of antibiotic treatment for 
pneumonia has not been established well in controlled studies. 
  
  
35 
 
However, antibiotics should generally be continued until  
• the patient has been afebrile for 72 hr and  
• the total duration should not be less than 10 days or  
• 5 days if azithromycin is used 
•  Shorter courses 5to7 days may also be effective particularly for 
children managed on an outpatient.  
Available data do not support prolonged courses of treatment for 
uncomplicated pneumonia. In developing countries like India  the 
supplementation oforal zinc 10 mg per day for less than 12 mo old infants 
and 20 mg per day for more than12 month old children reduces mortality 
among children with  severe pneumonia”. 
PROGNOSIS 
Within two to four days of starting the antibiotics uncomplicated 
community acquired pneumonia shows good response to treatment. There 
will be improvement of fever cough tachypnea and chest pain. 
Radiological evidence of improvement trails substantially behind clinical 
improvement.  
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When a patient did not improve with appropriate antibiotic therapy 
the following may be considered 
 complications like empyema   
 bacterial resistance 
 nonbacterial etiologies like viruse  fungus and aspirations  
 bronchial obstruction from endobronchial lesions and foreign body 
and mucous plugs 
 immunocompromised states and cystic fibrosis 
 pulmonary sequestration 
 congenital pulmonary airway malformation 
 “non infectious causes  
 bronchiolitis obliterans 
 hypersensitivity pneumonitis 
 eosinophilic pneumonia 
 aspiration 
 granulomatosis with polyangiitis 
  
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A repeat chest radiograph is the first step in determining the reason 
for delay in response to treatment. Broncho alveolar lavage may be 
indicated in children with respiratory failure; high-resolution CT scans 
may better identify complications or an ana- tomic reason for a poor 
response to therapy. 
Mortality from community-acquired pneumonia in developed 
nations is rare, and most children with pneumonia do not experience 
long-term pulmonary sequelae. Some data suggest that up to 45% of 
children have symptoms of asthma 5 yr after hospitalization for pneu- 
monia; this finding may reflect either undiagnosed asthma at the time of 
presentation or a propensity for development of asthma after pneumonia”. 
COMPLICATIONS 
The spread of the bacterial infection by directly into the thoracic 
cavity or spread through the blood and the presence of the bacteria in the 
blood stream is responsible for the complications of pneumonia . the 
direct spread causes empyema, pleural effusion and pericarditis. 
• Hemophilous influenza type b causes meningitis,  arthritis, 
osteomyelitis  
• Staphylococcus aureus, Streptococcus pneumoniae and 
Streptococcus causes para pneumonic effusions , empyema  
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Many of the effusions followed the  bacterial pneumonia were 
sterile. Even htough if the culture is negative the bacterial genome may 
be identified by the universal RNA gene polymerase chain reaction and 
can determine the bacterial etiology of the pleural effusion.  
Treatment of the empyema 
It is based on the stage of the empyema whether exudative or 
fibrino purulent or organizing. 
The stage of the empyema may be identified by the computed 
tomographic scan or by ultrasonogram. The main treatment for empyema 
area antibiotic therapy with chest tube drainage. The other treatments are 
the useage of intrapleural fibrinolytic therapy. The agents used are tissue 
plasminogen activator,streptokinase or urokinase.For the debridement of 
the adhesions and for the lysis of the lesions selected video assisted 
thoracoscopy may be used. This also help todrain the pus which is 
loculated. Thoracotomy and open debridementmay not be needed if there 
is prompt early diagnosis and management,especially with fibrinolysis 
and sometimes videoassisted thoracoscopy.among these two fibrinolysis 
is less costlier than video assisted thoracoscopy. 
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PREVENTION 
The invention of the vaccines and the extensive vaccinations 
grossly reduced the incidence of the pneumonia hospital admissions. The 
seven valent conjugate vaccine for pneumococcus was introduced in the 
early twentieth century. Following that there is almost thirty percent 
reduction in the occurrence of the pneumonia patients.  
Ten years after the introduction of the hepta valent vaccine the 
thirteen valent vaccine was introduced. This vaccine will further reduced 
the incidence of the pneumococcal disease. This vaccine has more strains 
which are not covered by the heptavalent vaccine. 
The difference between transudate and empyema are shown below: 
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 TRANSUDATE EMPYEMA 
Appearance Clear Cloudy or purulent 
Cell count Less than1,000 Often>50,000 
Cellular type Lymphocyte neutrophils 
LDH Less than 200 U/L 
>2/3 of the upper limit of 
normal for serum LDH 
Pleural fluid: serum 
LDH ratio 
Less than 0.6 More than 0.6 
Protein more than 3 gram Rare Common 
Pleural fluid:serum 
protein ratio 
Less than 0.5 More than 0.5 
Glucose level Normal Low less than40 mg per ml 
pH Normal 7.4 to7.6 Less than 7.1 
Gram staining Negative Sometimes positive 
Cholesterol  More than 55 mg per ml 
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ZINC 
Zinc is an “essential mineral that is naturally present in some 
foods, added to others and also available as a dietary supplement.  
Zinc is involved in many aspects of metabolism”of the human 
cells. It is necessary for the catalytic activity of more than three hundred 
enzymes. Also it plays a very important role in the immune functions of 
the human body and has many roles in protein synthesis and wound 
healing. Also it is very important in the process DNA synthesis  and in 
cell division.  Zinc also helps the normal growth and development at and 
during pregnancy and childhood adolescence and adults . It is  required 
for the special sense organs like tongue and the nose for taste and smell. 
As there is no separate storage system for zinc in our body. Hence daily 
intake of zinc is required to maintain a steady state in our body functions. 
Daily recommended intake  
The recommendations for intake of zinc are given inthe Dietary 
Reference Intakes developed by the Food and Nutrition Board  at the 
Institute of Medicine of the National Academies.  
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These values different for different  age and gender are 
• Recommended Dietary Allowance (RDA): average daily level of 
intake sufficient to meet the nutrient requirements of nearly all 
(97%–98%) healthy individuals. 
• Adequate Intake (AI): established when evidence is insufficient 
to develop an RDA and is set at a level assumed to ensure 
nutritional adequacy. 
• Tolerable Upper Intake Level (UL): maximum daily intake 
unlikely to cause adverse health effects [2]. 
The current RDAs for zinc are listed in Table 1 [2]. For infants 
aged 0 to 6 months, the FNB established an AI for zinc that is equivalent 
to the mean intake of zinc in healthy, breastfed infants. 
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 “Recommended Dietary Allowances for Zinc 
Age groups  Male Female
 Pregnancy Lactation 
Birth to six months 2 mg* 2 mg*  
7–12 months 3 mg 3 mg   
1–3 years 3 mg 3 mg   
4–8 years 5 mg 5 mg   
9–13 years 8 mg 8 mg   
14–18 years 11 mg 9 mg 12 mg 13 mg 
19+ years 11 mg 8 mg 11 mg 12 mg 
* Adequate Intake (AI)” 
Food sources of zinc 
Zinc is present in many varieties of food. Chicken and the meat are 
the main source of zinc in the world diet. In terms of the serving Oysters 
contain more zinc.the following are the major food sources  
• Beans 
• Nuts 
• certain types of seafood like crab and lobster 
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• whole grains 
• fortified breakfast cereals 
•  dairy products  
The phytates may bind zinc and inhibit the absorption of zinc in the 
food. They were present in whole grain breads, cereals, legumes. Hence 
"the bioavailability of zinc from grains and plant foods is lower than that 
from animal foods. But still many grain and plant based foods are still 
good sources of zinc. 
Dietary supplements 
Dietary Supplements contain different forms of zinc. They are zinc 
gluconate zinc sulfate and acetate. Each differs in percentage of elemental 
zinc varies by form. Approximately 23% of zinc sulfate consists of 
elemental zinc”. 
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VEG FOOD ITEMS WHICH IS HIGH IN ZINC 
       
        
         
 
These are the food materials of vegetable origin which have hiwgh 
zinc content. 
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NON VEG FOOD ITEMS 
 
                  
 
                    
 
The above food items are of animal origin which are rich source of 
zinc. 
  
47 
 
There is very less scientific evidence to determine  if any  
differences exist among the different forms of zinc in absorption, 
bioavailability or tolerability. 
Sources other than diet  
Zinc is present in several products like homeopathic medications 
which sold over the counter for the cure  and prevention of colds.  
Zinc is also present in some denture adhesive creams. The levels 
range from 17–34 mg per gram. chronic, excessive use can lead to zinc 
toxicity. Also this is resulting in copper deficiency and  also neurological 
disease. Many denture creams have now been reformulated to eliminate 
zinc. 
Zinc Deficiency 
Zinc deficiency causes 
• “growth retardation 
• loss of appetite 
• impaired immune function 
• hair loss 
• diarrhea 
• delayed sexual maturation 
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• impotence 
• hypogonadism in males  
•  eye and skin lesions  
• Weight loss 
• delayed healing of wounds 
• taste abnormalities 
• mental lethargy  
Many of these symptoms are not specific and  associated with other 
health conditions. So a medical evaluation  is necessary to find  whether a 
zinc deficiency is present. 
The Zinc nutritional status is difficult to estimate correctly  using 
laboratory tests”. Because zinc is distributed as a component of various 
proteins and nucleic acids. Plasma or serum zinc levels are the most 
commonly used indices for evaluating zinc deficiency. But these levels 
do not necessarily reflect cellular zinc status because of the tight 
homeostatic control mechanisms.  
Clinical effects of zinc deficiency can be present  with normal  
laboratory values. Physicians should  consider risk factors like  
inadequate caloric intake, alcoholism and gastrointestinal  diseases and 
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symptoms of zinc deficiency when determining the need for zinc 
supplementation. 
People with gastrointestinal and other diseases 
• Gastrointestinal surgery 
• digestive disorders like  ulcerative colitis, Crohn's disease 
• short bowel syndrome These can reduce zinc absorption and also 
increase endogenous zinc losses  
• malabsorption syndrome,  
• chronic liver disease 
• chronic renal disease 
• sickle cell disease, diabetes 
• malignancy 
• other chronic illnesses 
• Chronic diarrhea also leads to excessive loss of zinc 
Vegetarian diet  
“The bioavailability of zinc from vegetarian diets usually is less  
than from non vegetarian diets. Because  vegetarians do not eat meat 
which is high in bioavailable zinc and also will increase zinc absorption. 
Also  vegetarians mainly eat high levels of legumes and whole grains. 
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These food contain high level of  phytates . Phytates bind zinc and inhibit 
its absorption. So Vegetarians often require as much as fifty percent more 
of the RDA for zinc than non-vegetarians. 
There are some techniques which that reduce the binding of zinc by 
phytates and increase its bioavailability.  
Techniques to increase zinc bioavailability include  
1) soaking beans, grains, and seeds in water for several hours before 
cooking them and allowing them to sit after soaking until sprouts 
form  
2) by consuming more leavened grain products such as bread than 
unleavened products like crackers. 
 Leavening  partially breaks down the phytate. So  the body 
absorbs more zinc from leavened grains than unleavened grains”. 
Pregnancy and lactation 
Pregnant women especially become pregnant with marginal zinc 
status were at increased risk of becoming zinc insufficient. This is due in 
part to high fetal requirements for zinc. Lactation can also deplete 
maternal zinc stores. Hence the RDA for zinc is higher for pregnant and 
lactating women than for other women  
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Older infants on exclusive breast feeding  
Breast milk provides sufficient zinc for the baby for the first four to 
six months of life. But it do not provide recommended amounts of zinc 
for infants in the second half of the first year. The zinc requirements in 
the first six months is 2 mg per day whereas in the second half it will be 3 
mg per day. Zinc supplementation has improved the growth rate. Some  
children who demonstrate mild to moderate growth failure and who have 
a zinc deficiency showed good improvement. 
People with sickle cell disease 
Many patients with sickle cell anemia usually have zinc deficiency. 
In these children zinc supplementation will improve the growth. 
Alcoholism 
“Half of the alcoholics have low zinc status. Because ethanol 
consumption decreases intestinal absorption of zinc. Also it increases 
urinary zinc excretion. Also the variety and amount of food consumed by 
many alcoholics is very  limited and leading to inadequate zinc intake”. 
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BIOLOGICAL ROLE OF ZINC 
“Immune function 
Severe zinc deficiency reduces  immune function. Even  mild to 
moderate degrees of zinc deficiency may impair macrophage and 
neutrophil functions and  natural killer cell activity”. Also there is 
impairment of the complement activity . For  the development  and 
activation T-lymphocytes The body requires zinc .The “persons with low 
zinc levels have shown reduced lymphocyte proliferation response to 
mitogens. Also they have other adverse alterations in immunity. They can 
be corrected by zinc supplementation”.  This is the probable explanation 
for the increased susceptibility for the infections like pneumonia in 
children of the developing countries like India who have low zinc status. 
Wound healing 
The  integrity of skin and mucosal membranes is maintained by 
zinc. chronic leg ulcer patients may have abnormal zinc metabolism. 
They also have low serum zinc levels. Physicians  frequently treat skin 
ulcers with zinc supplements. In a systematic review concluded that zinc 
sulfate might be effective for treating leg ulcers in some patients with  
low serum zinc levels. 
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Diarrhoeal disorders 
“Acute diarrhea disorders  are associated with high rates of 
mortality among children in developing countries. The Zinc deficiency 
causes changes  in immune response which probably responsible for the 
increased susceptibility to infections. This is the basis of Zinc 
supplementation in children with diarrhoea. 
Many Studies show that poor, malnourished children in India and 
other developing countries may experience  shorter courses of infectious 
diarrhea following  zinc supplements. The children in these studies 
received 4 to 40 mg of zinc per day in the form of either zinc acetate, zinc 
gluconate or zinc sulfate  
The results from a pooled analysis of randomized controlled trial of 
zinc supplementation in developing countries states  that zinc helps 
reduce the duration and severity of diarrhea in zinc-deficient or otherwise 
malnourished children .  
Similar findings are  reported in a meta-analysis published in 2008 
and a 2007 review of zinc supplementation for preventing and treating 
diarrhea .The effects of zinc supplementation on diarrhea in children with 
adequate zinc status, such as most children in the developed countries like 
United States were  not clear. 
 The World Health Organization and UNICEF now recommends a 
short course of zinc supplementation to trea
WHO recommendations 
For infants less than 6 months 10 mg per day.
For more than six months 20 mg per day.
This should be given for a period of 10 to 14 days.
 “Interactions with iron and copper
Iron-deficiency anemia is a serious world
problem. Iron fortification programs have been credited with improving 
the iron status of millions of women, infants, and children. Fortification 
of foods with iron does not significantly affect 
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large amounts of supplemental iron (greater than 25 mg) might decrease 
zinc absorption [2,78]. Taking iron supplements between meals helps 
decrease its effect on zinc absorption [78]. 
High zinc intakes can inhibit copper absorption, sometimes 
producing copper deficiency and associated anemia [79,80]. For this 
reason, dietary supplement formulations containing high levels of zinc, 
such as the one used in the AREDS study [72], sometimes contain 
copper. 
Health Risks from Excessive Zinc 
Zinc toxicity can occur in both acute and chronic forms. Acute 
adverse effects of high zinc intake include nausea, vomiting, loss of 
appetite, abdominal cramps, diarrhea, and headaches [2]. One case report 
cited severe nausea and vomiting within 30 minutes of ingesting 4 g of 
zinc gluconate (570 mg elemental zinc) [81]. Intakes of 150–450 mg of 
zinc per day have been associated with such chronic effects as low copper 
status, altered iron function, reduced immune function, and reduced levels 
of high-density lipoproteins [82]. Reductions in a copper-containing 
enzyme, a marker of copper status, have been reported with even 
moderately high zinc intakes of approximately 60 mg/day for up to 10 
weeks [2]. The doses of zinc used in the AREDS study (80 mg per day of 
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zinc in the form of zinc oxide for 6.3 years, on average) have been 
associated with a significant increase in hospitalizations for genitourinary 
causes, raising the possibility that chronically high intakes of zinc 
adversely affect some aspects of urinary physiology [83]. 
The FNB has established ULs for zinc (Table 3). Long-term 
intakes above the UL increase the risk of adverse health effects [2]. The 
ULs do not apply to individuals receiving zinc for medical treatment, but 
such individuals should be under the care of a physician who monitors 
them for adverse health effects. 
Table 3: Tolerable Upper Intake Levels (ULs) for Zinc [2] 
Age Male Female  Pregnant Locating 
0–6 months 4 mg 4 mg   
7–12 months 5 mg 5 mg   
1–3 years 7 mg 7 mg   
4–8 years 12 mg 12 mg   
9–13 years 23 mg 23 mg   
14–18 years 34 mg 34 mg 34 mg 34 mg 
19+ years 40 mg 40 mg 40 mg 40 mg 
 
  
57 
 
Interactions with Medications 
Zinc supplements have the potential to interact with several types 
of medications. A few examples are provided below. Individuals taking 
these medications on a regular basis should discuss their zinc intakes with 
their healthcare providers”. 
Antibiotics 
Both quinolone antibiotics (such as Cipro®) and tetracycline 
antibiotics (such as Achromycin® and Sumycin®) interact with zinc in 
the gastrointestinal tract, inhibiting the absorption of both zinc and the 
antibiotic [84,85]. Taking the antibiotic at least 2 hours before or 4–6 
hours after taking a zinc supplement minimizes this interaction [86]. 
Penicillamine 
Zinc can reduce the absorption and action of penicillamine, a drug 
used to treat rheumatoid arthritis [87]. To minimize this interaction, 
individuals should take zinc supplements at least 2 hours before or after 
taking penicillamine [85]. 
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Diuretics 
Thiazide diuretics such as chlorthalidone (Hygroton®) and 
hydrochlorothiazide (Esidrix® and HydroDIURIL®) increase urinary 
zinc excretion by as much as 60% [88]. Prolonged use of thiazide 
diuretics could deplete zinc tissue levels, so clinicians should monitor 
zinc status in patients taking these medications. 
Zinc and Healthful Diets 
The federal government's 2010 Dietary Guidelines for Americans 
notes that “nutrients should come primarily from foods. Foods in 
nutrient-dense, mostly intact forms contain not only the essential vitamins 
and minerals that are often contained in nutrient supplements, but also 
dietary fiber and other naturally occurring substances that may have 
positive health effects. ...Dietary supplements...may be advantageous in 
specific situations to increase intake of a specific vitamin or mineral”. 
For more information about building a healthful diet, refer to the 
Dietary Guidelines for Americans and the U.S. Department of 
Agriculture's food guidance system, MyPlate . 
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The Dietary Guidelines for Americans describes a healthy diet as one 
that: 
• Emphasizes a variety of fruits, vegetables, whole grains, and fat-
free or low-fat milk and milk products. 
Whole grains and milk products are good sources of zinc. Many 
ready-to-eat breakfast cereals are fortified with zinc. 
• Includes lean meats, poultry, fish, beans, eggs, and nuts. 
Oysters, red meat, and poultry are excellent sources of zinc. Baked 
beans, chickpeas, and nuts (such as cashews and almonds) also contain 
zinc”. 
  
  
AGE 
< 1 yr 
1 -2 yr 
>2 -5 yr 
TOTAL 
 
28% of study population is less than one year and 40% is between 
one to two years. So a total of 68% 0f study population is below 2 
Only 32 persent  is more than 2 years and less than 5 years.
 
CASES
CONTROL
0%
5%
10%
15%
20%
25%
30%
35%
40%
45%
Age Distribution with Study Group [N=100][p>0.05]
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RESULTS AND ANALYSIS 
AGE DISTRIBUTION 
GENDER 
TOTAL 
MALE FEMALE 
16 12 28 
22 18 40 
14 18 32 
52 48 100 
< 1 yr 1 -2 yr
28% 40%
28% 40%
(%) 
28% 
40% 
32% 
  
years. 
  
 
>2 -5 yr
32%
32%
  
GENDER 
MALE 
FEMALE 
TOTAL 
 
In this study group 52 are male and 48 are female. There is
statistial significance in sex distribution.
 
 
 
 
 
 
MALE
FEMALE
46%
47%
48%
49%
50%
51%
52%
53%
Gender Distribution [N=100][p>0.05]
 
 
61 
SEX DISTRIBUTION 
STUDYGROUP 
TOTAL 
CASES CONTROL 
26 26 52 
24 24 48 
50 50 100 
 
CASES[n=50] CONTROL[n=50]
52% 52%
48% 48%
(%) 
52% 
48% 
  
 no 
 Sr.Zinc
>65 mcg
50 – 64 mcg
<50 mcg
Total 
 
In this study group of 100 children 50 children had serum zinc 
levels above 65mcg/dl and 50 children below this cut off.
Among the cases 40 children had serum zinc levels below 
65mcg/dl and 10 children above 65mcg/dl.
Among the controls 40 children had serum zinc levels above 
65mcg/dl and 10 children below 65mcg/dl
 
 
50 – 64 mcg
18%
<50 mcg
32%
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SERUM ZINC 
 n 
 50 
 18 
 32 
100 
 
 
 
>65 mcg
50%
Sr.Zinc  [n=50]
 SERUM ZINC LEVEL IN STUDY GROUP
Sr.Zinc 
LOW 
NORMAL 
TOTAL 
 
This low serum zinc levels being low in cases is statistically 
significant with p value <0.001. This shows that serum zinc level is low 
in severe pneumonia which is very 
. 
 
 
LOW
NORMAL
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
Sr.Zinc according in study group 
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STUDY GROUP 
TOTAL 
CASES CONTROL 
40 10 50 
10 40 50 
50 50 100 
significant 
 
CASES[n=50] CONTROL[n=50]
80% 20%
20% 80%
[N=100][p<0.001]
 
(%) 
50% 
50% 
  
 
 ASSOCIATION OF AGE WITH ZINC IN STUDY GROUPS
STUDY 
GROUP Age
CASES 
< 1 yr
1 
>2 
Total
CONTROL 
< 1 yr
1 
>2 
Total
 
There is no statistically significant association between serum zinc 
level and age. 
< 1 yr
LOW 79%
NORMAL 21%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Association of Age with Sr.Zn level [N=100][p>0.05]
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Serum Zinc Level 
Total 
LOW NORMAL 
 11 3 14 
-2 yr 17 3 20 
-5 yr 12 4 16 
 40 10 50 100%
 3 11 14 
-2 yr 2 18 20 
-5 yr 5 11 16 
 10 40 50 100%
1 -2 yr >2 -5 yr < 1 yr 1 -2 yr
CASES CONTROL
85% 75% 21% 10%
15% 25% 79% 90%
 
(%) Sig 
28%   
40% >0.05 
32%   
   
28%   
40% >0.05 
32%   
   
 
>2 -5 yr
31%
69%
 ASSOCIATION OF GENDER WITH SR.ZINC IN STUDY GROUPS
STUDY 
GROUP 
Gender
CASES 
Male
Female
Total
CONTROL 
Male
Female
Total
 
There is no statistically significant association between 
and gender. 
 
 
Zn LOW
Zn NORMAL
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Association of Gender with Sr.Zinc Level 
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Serum Zinc Level 
Total 
LOW NORMAL 
 22 4 26 52%
 18 6 24 48%
 40 10 50 100%
 8 18 26 52%
 2 22 24 48%
 10 40 50 100%
Male Female Male
CASES CONTROL
85% 75% 31%
15% 25% 69%
[N=100][p>0.05]
 
(%) Sig 
   
 >0.05 
   
   
 >0.05 
   
zinc level 
 
Female
8%
92%
 ASSOCIATION OF PLACE OF RESIDENCE WITH SERUM 
ZINC LEVELS IN STUDY GROUP.
STUDY 
GROUP 
Place
CASES 
C
M
K
O
T
Total
CONTROL 
C
M
Total
 
There is no statistically significant association between 
serum zinc level and place of residence.
C
LOW 78%
NORMAL 22%
0%
20%
40%
60%
80%
100%
120%
Association of Place with Sr.Zinc Level 
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Serum Zinc Level 
Total 
LOW NORMAL 
 28 8 36 
 3 0 3 
 2 0 2 
 1 0 1 
 6 2 8 
 40 10 50 100%
 10 38 48 
 0 2 2 
 10 40 50 100%
 
M K O T C
CASES CONTROL
100% 100% 100% 75% 21%
0% 0% 0% 25% 79%
[N=100][p>0.05]
(%) Sig 
72%   
6%   
4%   
2% >0.05 
16%   
   
96%   
4% >0.05 
   
 
M
0%
100%
 ASSOCIATION OF BREAST FEEDING WITH SERUM ZINC 
STUDY 
GROUP 
CASES 
Started at Birth
CONTROL 
 
There is no statistically significant association between serum zinc level and 
breast feeding starting time.
 
 
 
Started at Birth
LOW
NORMAL
0%
20%
40%
60%
80%
100%
120%
Association of Breast Feeding with Sr.Zinc Level 
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LEVELS IN STUDY GROUP 
Breast Serum Zinc Level 
Total 
Feeding LOW NORMAL 
 36 10 46 
Not Started 4 0 4 
Total 40 10 50 
Not started 10 40 50 
Total 10 40 50 
 
Not Started
CASES
78% 100%
22% 0%
[N=100][p>0.05]
(%) Sig 
92%   
8% >0.05 
100%   
100%   
100%   
 
Not Started
CONTROL
20%
80%
 ASSOCIATION  OF BREST FEEDING DURATION WITH 
SERUM ZINC LEVELS IN STUDY GROUP
STUDY 
GROUP 
CASES 
Till Date/NA
CONTROL 
Till Date/NA
 
There is no statistically significant association between serum zinc 
level and breast feeding duration.
< 6 mon
LOW 100%
NORMAL 0%
0%
20%
40%
60%
80%
100%
120%
Association of Breast Feeding  duration with Sr.Zinc 
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Duration 
Serum Zinc Level 
Total 
LOW NORMAL 
< 6 mon 6 0 6 
6 M – 1 yr 25 8 33 
> 1yr 0 1 1 
 9 1 10 
Total 40 10 50 
< 6 mon 2 1 3 
6 M – 1 yr 7 23 30 
> 1yr 0 9 9 
 1 7 8 
Total 10 40 50 
 
6 M – 1 
yr
> 1yr
Till 
Date/NA
< 6 mon
6 M – 1 
yr
CASES CONTROL
76% 0% 90% 67% 23%
24% 100% 10% 33% 77%
Level [N=100][p>0.05]
 
(%) Sig 
12%   
66%   
2% >0.05 
20%   
100%   
6%   
60%   
18%   
16% >0.05 
100%   
 
> 1yr
Till 
Date/NA
0% 13%
100% 88%
 ASSOCIATION  OF BREST FEEDING WEANING WITH S
ZINC LEVELS IN STUDY GROUP
STUDY 
GROUP 
CASES 
Not Yet/ NA
CONTROL 
Not Yet/ NA
 
There is no statistically significant 
level and breast feeding weaning.
< 6 mon
LOW 82%
NORMAL 18%
0%
20%
40%
60%
80%
100%
120%
Association of Breast Feeding weaning with Sr.Zinc Level 
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Weaning 
Serum Zinc Level 
Total 
LOW NORMAL 
< 6 mon 9 2 11 
> 6 mom 29 7 36 
 2 1 3 
Total 40 10 50 
< 6 mon 4 18 22 
> 6 mom 6 17 23 
 0 5 5 
Total 10 40 50 
association between serum zinc 
 
> 6 mom Not Yet/ NA < 6 mon > 6 mom
CASES CONTROL
81% 67% 18% 26%
19% 33% 82% 74%
[N=100][p>0.05]
ERUM 
(%) Sig 
22%   
72% >0.05 
6%   
100%   
44%   
46%   
10% >0.05 
100%   
 
 
Not Yet/ NA
0%
100%
 ASSOCIATION  OF MIXED FEEDS WITH SERUM ZINC LEVELS 
STUDY 
GROUP 
Mixed Feeds
CASES 
COWS MILK
FORMULA MILK
BOTH
Total
CONTROL 
COWS MILK
FORMULA MILK
Total
 
There is  statistically significant association between serum zinc level 
mixed feeds 
COWS 
MILK
LOW 85%
NORMAL 15%
0%
20%
40%
60%
80%
100%
120%
Association of Mixed Feeds  with Sr.Zinc Level 
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IN STUDY GROUP 
 
Serum Zinc Level 
Total
LOW NORMAL 
 17 3 20 
 6 0 6 
 2 0 2 
NIL 15 7 22 
 40 10 50 
 6 2 8 
 0 4 4 
NIL 4 34 38 
 10 40 50 
FORMULA 
MILK
BOTH NIL
COWS 
MILK
FORMULA 
CASES CONTROL
100% 100% 68% 75%
0% 0% 32% 25%
[N=100][p>0.05]
 
 (%) Sig 
40%   
12% >0.05 
4%   
44%   
100%   
16%   
8%   
76% <0.05 
100%   
and 
 
MILK
NIL
0% 11%
100% 89%
 ASSOCIATION OF BIRTH WEIGHTWITH SERUM ZINC 
STUDY 
GROUP 
CASES 
<2.5 KG
>2.5 KG
CONTROL 
<2.5 KG
>2.5 KG
 
There is  statistically significant association between serum zinc 
level and birth weight
 
 
 
<2.5 KG
Zn LOW 100%
Zn NORMAL
0%
20%
40%
60%
80%
100%
120%
Association of Birth weight  with Sr.Zinc Level 
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LEVELS IN STUDY GROUP 
Birth Serum Zinc Level 
Total 
Weight LOW NORMAL 
 11 0 11 
 29 10 39 
Total 40 10 50 
 2 1 3 
 8 39 47 
Total 10 40 50 
. 
 
2.5 KG <2.5 KG 2.5 KG
CASES CONTROL
74% 67% 17%
0% 26% 33% 83%
[N=100][p<0.05]
(%) Sig 
22%   
78% <0.05 
100%   
6%   
94% <0.05 
100%   
 
 ASSOCIATION  OF FEBRILE SEIZURE WITH LOW S
ZINC LEVELS IN STUDY GROUP
STUDY 
GROUP 
Febrile
Seizure
CASES 
Present
Absent
Total
CONTROL 
Present
Absent
Total
 
There is  statistically significant 
zinc level and febrile seizure
 
 
Present
Zn LOW
Zn NORMAL
0%
20%
40%
60%
80%
100%
120%
Association of Febrileseizure with Sr.Zinc Level 
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 Serum Zinc Level  
Total  LOW NORMAL 
 7 0 7 
 33 10 43 
 40 10 50 100%
 1 0 1 
 9 40 49 
 10 40 50 100%
association between  low serum 
. 
Absent Present
CASES CONTROL
100% 77% 100%
0% 23% 0%
[N=100][p<0.05]
ERUM 
 
(%) 
 
Sig 
14% 
86% <0.05 
 
2% 
98% <0.05 
 
 
Absent
18%
82%
 ASSOCIATION  OF NUMBER OF ILLNESSES WITHIN LAST 6 
MONTHS WITH LOW SERUM ZINC LEVELS IN
 
STUDY 
GROUP 
No of 
illness in 
last 6 mths
CASES 
One time
Two times
NIL
Total
CONTROL 
NIL
Total
 
There is  statistically significant association between serum zinc 
level and number of illnessess in last 6 months 
 
One time
NORMAL
MILD LOW
LOW
0%
20%
40%
60%
80%
100%
120%
Association of No.of Illness with Sr.Zinc Level 
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 STUDY GROUP
 
Serum zinc level 
 
Low 
 
Total
Normal Mild low 
 10 9 24 43 
 0 4 1 5 
 0 0 2 2 
 10 13 27 50 
 40 5 5 50 
 40 5 5 50 
 
.
Two times NIL
23% 0% 0%
21% 80% 0%
56% 20% 100%
[N=100][p<0.05]
 
 
 
(%) 
 
Sig 
86%   
10% <0.05 
4%   
100%   
100%   
100%   
 
NIL
80%
10%
10%
 ASSOCIATION  OF TWIN/PRETERM PREGNANCY WITH LOW 
SERUM ZINC LEVELS IN STUDY GROUP
 
STUDY 
GROUP 
Preterm
CASES 
Yes 
No 
Total
CONTROL 
No 
Total
 
There is no  statistically significant association between serum zinc 
level and twin/preterm 
 
 
NORMAL
MILD LOW
LOW
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
Association of H/o preterm  with Sr.Zinc Level 
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Serum Zinc Level 
Low Total 
Normal Mild Low 
0 1 2 3 
10 12 25 47 
 10 13 27 50 
40 5 5 50 
 40 5 5 50 
pregnancy. 
Yes No
0% 21%
33% 26%
67% 53%
[N=100][p>0.05]
 
(%) Sig 
6%   
94% >0.05 
100%   
100%   
100%   
 
No
80%
10%
10%
 ASSOCIATION OF  CALORIC GAP  WITH LOW SERUM ZINC 
STUDY 
GROUP 
Caloric 
Gap
CASES 
Present
Absent
NA 
Total
CONTROL 
Present
Absent
NA 
Total
 
There is no significant association between caloric gap with low 
serum zinc level in this study group
Present
NORMAL 11%
MILD LOW 17%
LOW 72%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Association of Caloric Gap with Sr.Zinc Level 
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LEVEL IN STUDY GROUP 
 
Serum Zinc Level 
Low Total
Normal Mild Low 
 2 3 13 18
 8 9 10 27
0 1 4 5
 10 13 27 50
 6 3 2 11
 29 2 2 33
5 0 1 6
 40 5 5 50
. 
Absent NA Present Absent
30% 0% 55% 88%
33% 20% 27% 6%
37% 80% 18% 6%
[N=100][p>0.05]
 (%) Sig 
 36%   
 54% >0.05 
 10%   
 100%   
 22%   
 66%   
 12% >0.05 
 100%   
 
NA
83%
0%
17%
 ASSOCIATION OF PROTEIN GAP 
STUDY 
GROUP Protein Gap
CASES 
Present
Absent
NA
Total
CONTROL 
Present
Absent
NA
Total
 
There is no significant association between  protein gap with low 
serum zinc level in this study group
 
Present
NORMAL 18%
MILD LOW 24%
LOW 59%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Association of Protein Gap with Sr.Zinc Level 
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 WITH LOW SERUM ZINC 
LEVEL IN STUDY GROUP 
 
Serum Zinc Level  
Low 
 
Total Normal Mild Low 
 3 4 10 17
 7 8 13 28
 0 1 4 5 
 10 13 27 50
 3 3 1 7 
 32 2 3 37
 5 0 1 6 
 40 5 5 50
. 
Absent NA Present Absent
25% 0% 43% 86%
29% 20% 43% 5%
46% 80% 14% 8%
[N=100][p>0.05]
 
 
(%) 
 
Sig 
 34%   
 56% >0.05 
10%   
 100%   
14%   
 74%   
12% <0.05 
 100%   
 
NA
83%
0%
17%
 ASSOCIATION OF FOOD INTAKE WITH SERUM ZINC
STUDY 
GROUP Intake
CASES 
Veg
Egg only
Non Veg
NA
Total
CONTROL 
Veg
Egg only
Non 
NA
Total
 
There is significant association between type of food intake and serum 
zinc levels. Low serum zinc level is associated with vegetarian diet.
 
Veg
NORMAL 9%
MILD LOW 32%
LOW 59%
0%
20%
40%
60%
80%
100%
120%
Association of Food Intake with Sr.Zinc Level 
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 IN STUDY GROUP 
 
 
Serum Zinc Level 
Low Total
Normal Mild Low 
 2 7 13 22
 0 4 3 7
 7 2 9 18
 1 0 2 3
 10 13 27 50
 5 3 5 13
 2 1 0 3
Veg 29 1 0 30
 4 0 0 4
 40 5 5 50
Egg only Non Veg NA Veg Egg only
0% 39% 33% 38% 67%
57% 11% 0% 23% 33%
43% 50% 67% 38% 0%
[N=100][p<0.05]
 
 (%) Sig 
 44%   
 14%   
 36% <0.05 
 6%   
 100%   
 26%   
 6%   
 60%   
 8% <0.05 
 100%   
 
 
Non Veg NA
97% 100%
3% 0%
0% 0%
 ASSOCIATION OF TUBER INTAKE WITH LOW SERUM 
 
STUDY 
GROUP 
Tubers 
Intake
CASES 
Yes
No 
Total
CONTROL 
No 
Total
 
There is no significant 
serum zinc level in this study group. This may be due to 68% of study 
population falls below 2 years .so no association could be seen.
 
NORMAL
MILD LOW
LOW
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
Association of Tubers Intake with Sr.Zinc Level 
 
 
78 
ZINC LEVEL 
 
Serum Zinc Level 
Low Total
Normal Mild Low 
 0 2 2 4 
10 11 25 46 
 10 13 27 50 
40 5 5 50 
 40 5 5 50 
association between tuber intake and low 
Yes No
0% 22%
50% 24%
50% 54%
[N=100][p>0.05]
 
 (%) Sig 
8%   
92% >0.05 
100%   
100%   
100%   
 
 
No
80%
10%
10%
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ASSOCIATION OF VARIOUS EXAMINATION FINDING WITH 
LOW SERUM ZINC LEVELS 
DEVELOPMENTAL MILESTONES  
NORMAL 39 80% 10 20%   
ABNORMAL 1 100% 0 0% >0.05 
IMMUNIZATION HISTORY 
UPTODATE 37 80% 9 20%   
PARTIALLY IMMUNISED 3 75% 1 25% >0.05 
FAMILY H/O SEIZURE  
PRESENT  1 100% 0 0%   
ABSENT 39 80% 10 20% >0.05 
 
Physical Examination according to cases 
  
  
Serum Zinc Level   
  
  
SIG LOW   NORMAL 
PALLOR           
PRESENT  1 100% 0 0%   
ABSENT 39 80% 10 20% >0.05 
ICTERUS           
PRESENT  3 100% 0 0%   
ABSENT 37 79% 10 21% >0.05 
DYSMORPHOLOGY         
ABSENT 40 80% 10 20% >0.05 
signs of  vit def.         
ABSENT 40 80% 10 20% >0.05 
All parameters discussed here do not have significant association 
with low serum zinc level. 
 Serum Zinc
NORMAL 
HR 
TACHYCARDIA
NORMAL
MILD 
LOW 
HR 
TACHYCARDIA
NORMAL
LOW 
HR 
TACHYCARDIA
NORMAL
 
There is significant association with low 
tachycardia. 
TACHYCARDIA
GROUP CASES
GROUP CONTROLS
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
Association of HR with Sr.Zinc Level [n=50][p<0.001]
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VITALS 
HEART RATE WITH Zn LEVELS 
 
GROUP 
Total
CASES CONTROLS 
 10 0 
 0 40 
Total 10 40 
 13 0 
 0 5 
Total 13 5 
 27 0 
 0 5 
Total 27 5 
serum zinc level and 
NORMALTACHYCARDIANORMALTACHYCARDIA
HR HR
NORMAL MILD LOW
20% 0% 72% 0% 84%
0% 80% 0% 28% 0%
 Sig 
10 
 
40 <0.001 
50 
 
13 
 
5 <0.001 
18 
 
27 
 
5 <0.001 
32 
 
 
NORMAL
HR
LOW
0%
16%
 ASSOCIATION OF SERUM ZINC LEVEL WITH RESPIRATORY RATE
RESPIRATORY RATE WITH Zn LEVELS
Serum Zinc
NORMAL 
RR 
MILD LOW 
RR 
LOW 
RR 
Low serum zinc level is associated with tachypnea with statistical significance.
 
GROUP CASES
GROUP CONTROLS
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
Association of RR with Sr.Zinc Level [n=50][p<0.001]
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GROUP 
CASES CONTROLS 
TACHYPNEA 10 0 
NORMAL 0 40 
Total 10 40 
TACHYPNEA 13 0 
NORMAL 0 5 
Total 13 5 
TACHYPNEA 27 0 
NORMAL 0 5 
Total 27 5 
 
 
TACHYPNEA NORMAL TACHYPNEA NORMAL TACHYPNEA
RR RR
NORMAL MILD LOW
20% 0% 72% 0% 84%
0% 80% 0% 28% 0%
 
Total Sig 
10 
 
40 <0.001 
50 
 
13 
 
5 <0.001 
18 
 
27 
 
5 <0.001 
32 
 
 
 
NORMAL
RR
LOW
0%
16%
 ASSOCIATION OF  LOW SERUM ZINC LEVELS
OXYGEN SATURATION VALUES
STUDY 
GROUP 
 
SPO2 
CASES 
>92% 
<92% 
<90% 
Total 
 
In this study there is significant 
zinc level and low oxygen saturation.
 
 
CASES >92%
CASES <92%
CASES <90% 
0%
10%
20%
30%
40%
50%
60%
70%
80%
Association of SPO2  with Sr.Zinc Level [n=50][p<0.001]
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Serum Zinc Level 
Low Total 
Normal Mild Low 
10 2 2 14 
0 4 6 10 
 0 7 19 26 
10 13 27 50 
association between low serum 
 
 
NORMAL MILD LOW
71% 14%
0% 40%
0% 27%
  WITH 
(%) Sig 
28%   
20%   
52% <0.001 
100%   
 
LOW
14%
60%
73%
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ASSOCIATION OF SERUM ZINC LEVEL WITH  
RESPIRATORY DISTRESS 
Serum Zinc 
GROUP 
Total Sig 
CASES CONTROLS 
NORMAL 
RS 
SUBCOSTAL  / 
INTERCOSTAL RETRACTION 
10 0 10 
 
NORMAL 0 40 40 <0.001 
Total 10 40 50 
 
MILD 
LOW 
RS 
SUBCOSTAL /INTERCOSTAL 
RETRACTION 
13 0 13 
 
NORMAL 0 5 5 <0.001 
Total 13 5 18 
 
LOW 
RS 
SUBCOSTAL /INTERCOSTAL 
RETRACTION 
20 0 20 
 
SUPRA STERNAL 
RETRACTION 
7 0 7 
 
NORMAL 0 5 5 <0.001 
Total 27 5 32 
 
 
Low serum zinc levels are significantly associated with increased 
respiratory distress. 
 
 
  
GROUP CASES
GROUP CONTROLS
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
Association of RS  with Sr.Zinc Level [n=50][p<0.001]
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SC/IC NORMAL SC/IC NORMAL SC/IC 
RS RS
NORMAL MILD LOW
20% 0% 72% 0% 63%
0% 80% 0% 28% 0%
 
SSR NORMAL
RS
LOW
22% 0%
0% 16%
 ASSOCIATION OF LEUCOCYTOSIS WITH LOW SERUM 
STUDY 
GROUP 
Leucocytosis
CASES 
Present
Absent
Total
 
There is significant association between low serum zinc levels and 
leucocytosis. This is may be due to defective immune mechanism 
associated with low level of zinc.
 
 
 
 
NORMAL
Present
Absent
0%
10%
20%
30%
40%
50%
60%
70%
80%
Association of TC  with Sr.Zinc Level [n=50][p<0.05]
 
 
85 
ZINC LEVELS 
 
Serum Zinc Level 
Low Total
Normal Mild Low 
 3 6 20 29
 7 7 7 21
 10 13 27 50
 
MILD LOW
10% 21%
33% 33%
 
 (%) Sig 
 58%   
 42% <0.05 
 100%   
 
LOW
69%
33%
 ASSOCIATION OF SERUM 
 
STUDY 
GROUP 
CHEST X RAY
CASES 
BRONCHO 
PNEUMONIA
CONSOLIDATION
Total
 
There is significant association 
of pneumonia. 
 
BRONCHO PNEUMONIA
CONSOLIDATION
10%
20%
30%
40%
50%
60%
Association of Chest X ray  with Sr.Zinc Level 
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ZINC LEVEL AND TYPE OF 
PNEUMONIA 
 
Serum Zinc Level 
Low Total
Normal 
Mild 
Low 
 7 10 21 
 3 3 6 
 10 13 27 
between serum zinc level and type 
NORMAL MILD LOW
18% 26%
25% 25%
0%
[n=50][p>0.05]
 (%) Sig 
38 76%   
12 24% >0.05 
50 100%   
 
LOW
55%
50%
 ASSOCIATION BETWEEN LOW SERU
STUDY 
GROUP 
Hospital 
stay 
CASES 
< 7 Days
> 7 Days
Total
 
There is no significant association between low serum zinc level 
and hospital stay in this study
 
 
 
 
NORMAL
< 7 Days
> 7 Days
0%
10%
20%
30%
40%
50%
60%
70%
Association of Hosptial stay with Sr.Zinc Level 
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M ZINC LEVEL AND 
HOSPITAL  STAY 
Serum Zinc Level 
Low Total 
Normal Mild Low 
 8 13 19 40 
 2 0 8 10 
 10 13 27 50 
. 
 
MILD LOW
21% 34%
17% 0%
[n=50][p>0.05]
(%) Sig 
80%   
20% >0.05 
100%   
 
LOW
50%
67%
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Statistical Analysis:  
  The qualitative variables as expressed in frequency and percentage. 
A Chi Square test was used to assess differences in categoric 
variables between groups. 
  Odds ratio was uesd to assess the variables. 
  A p value of <0.05 using a two-tailed test was taken as being of 
significance for all statistical tests. All data were analysed with a 
statistical software  package. (SPSS, version 16.0 for windows) 
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DISCUSSION 
 
This study is a case control study involving 50 cases and 50 
controls. All age, sex and nutrition matched controls. Age group from 6 
months to 5 years. 
Among the study group, 
 68% belong to age less than 2 years. 
 Malnourished children as per exclusion criteria are excluded. 
As the majority study group belongs to age less than 2 years, this 
has impact on food intake, and no association could be made between 
tuber intake and low serum zinc level. 
In this study there is strong association between severe pneumonia( 
both lobar and bronchopneumonia) and low serum zinc level which is 
similar to study done by Md. Salin shakur, et al, 2003; and study by Saket 
Kumar , et al in 2003; and study by Secil Arica, et al in 2011. 
Also lower the serum zinc level the higher the respiratory distress 
and associated with lower saturation levels which is similar to study by 
Hanaa I. Rady, et al in 2013. 
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In our  study there was a slight predominance of male cases, which 
was also recorded in various other studies.  This was explained by the fact 
of increased concern over the male children than the female children. 
In this study there was a significant association between febrile 
seizure and low serum zinc level as noticed in various other studies.    
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SUMMARY 
1. Serum zinc levels in children with severe pneumonia are low and 
they are statistically significant with p value of 0.001. about 80% 
of children with severe pneumonia had low serum zinc levels. 
2. A slight preponderance of male is seen in the study group , 
probably social reasons which give more attention to male child 
may be the reason. 
3. In this study group no association between low serum zinc level 
and variables like age, sex, place of residence, duration of breast 
feeding, time of weaning, preterm/twin pregnancy, calorie and 
protein gap were noted. 
4. Also there was no significant association between low serum zinc 
level and developmental milestones, immunization history and 
family history of seizures. 
5. In this study there was strong association between low serum zinc 
level and mixed feeds. So exclusive breast feeding seems to be 
protective against zinc deficiency. 
6. Low birth weight has strong association with low serum zinc level. 
7. Low serum zinc levels have significant association with febrile 
seizures 
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8. Increased frequency of illness in past 6 months is associated with 
low serum zinc levels. 
9. This study shows strong association of low serum zinc levels with 
vegetarian diet. Non vegetarian diet is protective against zinc 
deficiency. 
10. As 68% of study population is less than 2 years of age, intake of 
tubers does not have significant association with low serum zinc 
level. 
11. In this study low serum zinc is associated with tachypnea, 
increased respiratory distress and low oxygen saturation. 
12. Also low serum zinc level is associated with leucocytosis 
significantly and this may be due to increased susceptibility to 
infection. 
13. Low serum zinc level does not have significant association with 
type of pneumonia that is lobar pneumonia or bronchopneumonia. 
14. In this study there is no association between low serum zinc level 
and hospital stay. This may be due to appropriate antibiotics and 
supportive measures used to treat pneumonia.   
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CONCLUSION 
 
In conclusion, children with severe pneumonia have low serum 
zinc levels and thus “Low serum zinc level is a marker of severe 
pneumonia” 
Also lower the serum zinc level the higher the respiratory distress 
and associated significantly with low oxygen saturation. 
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PROFORMA 
 
NAME         DATE  
AGE     
SEX  
ADDRESS  
INFORMANT   
 
BREAST FEEDING  
• STARTED  
• DURATION  
• WEANING  
• MIXED FEEDS  
BIRTH HISTORY 
 BIRTH WEIGHT H/O PROGRESSIVE PALLOR 
 H/O FEBRILE SEIZURES 
 NO. OF ILLNESS EPISODES DURING LAST 6 MONTH  
 ORDER OF BIRTH 
 H/O PRETERM /TWIN PREGNANCY 
DIET HISTORY 
 CALORIC GAP 
 PROTEIN G 
 VEG/NON-VEG 
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 H/O INTAKE OF TUBERS 
 DEVELOPMENTAL MILESTONES  
 IMMUNIZATION HISTORY  
 FAMILY HISTORY 
PHYSICAL EXAMINATION 
 APPEARANCE       VITALS 
 DYSMORPHISM 
 PALLOR 
 ICTERUS 
 SIGNS OF VITAMIN DEFICIENCY 
SYSTEMIC EXAMINATION 
 CVS   
 RS 
 ABD  
 CNS 
INVESTIGATIONS 
 CBC  
 CHEST X-RAY 
 SERUM ZINC LEVELS 
 Duration of hospital stay  
 outcome   
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CONSENT FORM 
 
 Your child ………………… is being asked to be a participant is 
the research study titled "LOW SERUM ZINC LEVEL –POSSIBLE 
MARKER OF SEVERE PNEUMONIA" in CMCH,  Coimbatore, 
conducted by Dr. Kavitha .D, Post graduate student, Department of 
Paediatrics, Coimbatore Medical College Hospital your Child is eligible 
after looking on the inclusion criteria.  You can able any question you 
may have, before agreeing to participate. 
RESEARCH BEING DONE: To determine the prevalence of LOW 
SERUM ZINC LEVEL –POSSIBLE MARKER OF SEVERE 
PNEUMONIA.. 
PURPOSE OF RESEARCH:  
To find it association of  LOW SERUM ZINC LEVEL –
POSSIBLE MARKER OF SEVERE PNEUMONIA. 
PROCEDURE: Investigated as per protocol 
DECLINE FROM PARTICIPATION: You have the option to decline 
from participation in the study existing protocol for your condition. 
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PRIVACY AND CONFIDENTIALITY: Privacy of the individuals will 
be respected and any information about your child provided by you 
during the study will be kept strictly confidential. 
AUTHORIZATION TO PUBLISH RESULTS: Results of the study 
may be published for scientific purpose and / or presented to scientific 
groups; however your child will not be identified. 
STATEMENT OF CONSENT: 
I volunteer and consent my child to participate in the study. I have read 
the consent or it has been read to me. The study has been fully explained 
to me, and I may ask questions at any time. 
 
 
…………………………     ……………………… 
Signature / left thumb impression of parent  Date: 
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xg;g[jy; gotk;; [ ; ;; [ ; ;; [ ; ; 
 
bgah;     : 
taJ     : 
ghypdk;    : 
Kfthp    : 
 
muR nfhit kUj;Jtf; fy;Yhhpapy; FHe;ijfs; ey kUj;Jt 
Jiwapy; gl;l nkw;gog;g[ gapYk; khztp jpUkjp o. ftpjh mth;fs; 
nkw;bfhs;Sk; "epnkhdpah Vw;gl ,uj;jj;jpy; Jj;jehfk; FiwghL ; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ;
Kf;fpa fhuzkh>;;; " gw;wpa Ma;tpy; bra;Kiw kw;Wk; midj;J 
tpsf;f';fisa[k; nfl;Lf; bfhz;L vdJ re;njf';fis bjhpt[gLj;jpf; 
bfhz;nld; vd;gij bjhptpj;Jf; bfhs;fpnwd;. 
 
ehd; ,e;j Ma;tpy; KG rk;kjj;JlDk;/ Ra rpe;jida[lDk; 
fye;J bfhs;s rk;kjpf;fpnwd;. 
 
,e;j Ma;tpy; vd;idg; gw;wpa midj;J tpgu';fs; ghJfhf;fg; 
gLtJld; ,jd; Kot[fs; Ma;tpjHpy; btspaplg;gLtjpy; Ml;nrgiz 
,y;iy vd;gij bjhptpj;Jf; bfhs;fpnwd;. ve;j neuj;jpYk; ,e;j 
Ma;tpy; ,Ue;J ehd; tpyfpf; bfhs;s vdf;F chpik cz;L 
vd;gija[k; mwpntd;. 
 
,lk; 
njjp  
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HR RR Spo2 
T
C
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b
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S
e
r
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Z
i
n
c
 
1 MAHESWARI T 3 F 1 1 2 1 2 A A P 2 N P P 3 Y N 1 A P A A A 1 1 1 1 A P 1 2 1 1 
2 MUTHUKUMAR C 1 M 1 2 3 3 2 A A 0 1 N A A 4 N N 1 A A A A A 1 1 1 1 A A 1 1 1 1 
3 MOHAMMED TOFIQ C 1 M 1 4 1 3 1 A A 0 1 T NA NA 2 N N 1 A A A A A 1 1 1 1 P A 2 2 1 1 
4 RUBINA MARY C 2 F 1 2 2 3 2 A A 0 2 N P P 3 N N 1 A A A A A 1 1 1 1 A A 1 1 1 1 
5 HARINI M 2 F 2 NA NA 2 1 A A 0 1 N A A 2 N N 1 A A A A A 1 1 2 1 P A 1 2 1 1 
6 KEERTHNA C 1 F 1 2 2 3 2 A A 0 1 N A A 1 N N 1 A A A A A 1 1 1 1 P A 1 1 1 1 
7 FIYAS T 2 F 1 2 1 3 2 A P 0 2 N P P 2 N N 2 A A A A A 1 1 3 2 P A 1 3 2 1 
8 GOKUL C 2 M 1 2 1 3 2 A A 0 1 N A A 3 N N 1 A A A A A 1 1 1 1 A A 1 1 1 1 
9 SANJAY KUMARI C 2 F 1 1 2 4 1 A A 1 1 N A P 1 N N 1 A A A A A 1 1 3 1 A A 1 2 1 1 
10 YUVARAJ C 2 M 1 2 2 2 2 A A 1 2 N A A 1 N N 1 A A A A A 1 1 3 1 A A 2 2 1 1 
11 GOPIKA C 1 F 1 4 2 4 2 A A 1 1 N A A 1 N N 1 A A A A A 1 1 2 1 A A 1 2 1 1 
12 RAJADURAI T 2 M 1 1 1 1 2 A A 0 1 N P P 2 N N 1 A A A A A 1 1 3 1 P P 1 3 2 1 
13 DHARANISH C 3 M 1 2 2 1 2 A A 0 1 N A A 3 N N 1 A A A A A 1 1 3 1 P A 2 3 1 1 
14 JEEVITHA T 3 F 1 2 2 1 2 A A 0 1 N A A 3 N N 2 A A A A A 1 1 1 1 P P 1 1 1 1 
15 SUBASH T 2 M 1 1 1 1 1 A A 0 1 N A A 1 N N 1 A A A A A 1 1 2 1 P P 1 3 1 1 
16 Sanjay  C 2 M 1 2 2 1 2 A A 0 1 N A P 3 N N 1 A A A A A 1 1 1 1 P A 2 1 2 1 
17 DEEPIKASRI C 2 F 1 2 2 1 1 A P 0 2 N P P 1 N N 1 A A A A A 1 1 3 2 P P 1 3 1 1 
18 LATHAPANDY M 1 F 1 4 2 3 2 A A 0 1 N A A 1 N N 1 A A A A A 1 1 2 1 A A 1 2 1 1 
19 LITHIKASREE C 3 F 1 2 2 1 2 A A 2 2 N P P 3 N N 1 A A A A A 1 1 3 2 P P 1 3 2 1 
20 SATHYAMOORTHY C 2 M 2 2 1 3 2 A A 0 1 N A A 3 N N 1 A A A A A 1 1 3 1 P P 2 2 1 1 
21 MADHUMITHA C 3 F 1 3 1 3 2 A A 0 1 N A A 3 N N 1 A A A A A 1 1 1 1 A A 2 1 2 1 
22 DIVYABHARATHI C 3 F 1 2 2 1 2 A A 0 2 N P P 2 P N 1 A A A A A 1 1 3 1 A A 1 2 1 1 
23 HANIFA C 3 F 1 2 2 1 2 A A 0 2 N P P 3 N N 1 A A A A A 1 1 1 1 A A 2 1 1 1 
24 KANIMOZHI T 1 F 1 4 2 3 2 A A 0 1 N A A 1 N N 1 A A A A A 1 1 1 1 A A 1 1 1 1 
25 ASIFA K 3 F 1 2 1 2 1 A P 0 2 N P P 3 Y N 1 A A A A A 1 1 2 1 P P 2 3 2 1 
26 MOHAN T  2 M 1 2 2 1 2 A A 0 2 N A A 3 N N 1 A A A A A 1 1 3 1 P A 1 3 1 1 
27 MANIKANDAN C 2 M 1 2 2 2 2 A A 0 1 N P P 2 N N 1 A A A A A 1 1 2 1 P A 1 2 1 1 
  
108 
 
28 SRIRAM O 1 M 1 2 2 1 2 A A 0 1 N A A 1 N N 1 A A A A A 1 1 3 1 P A 1 2 1 1 
29 PRADEEP C 1 M 1 2 2 3 2 A A 0 1 N A A 1 N N 1 A A A A A 1 1 2 1 P A 1 3 1 1 
30 AISHA NAZREEN C 3 F 1 2 2 3 1 A A 0 2 Y/T P P 1 N N 2 A A P A A 1 1 2 1 P A 2 3 2 1 
31 JEEVITHA C 1 F 1 2 2 3 1 A A 0 1 N A A 1 N N 1 A A A A A 1 1 3 1 A A 1 2 1 1 
32 SRINIKA C 2 F 2 NA 1 1 2 A P 0 3 N P P 1 N N 2 A A P A A 1 1 3 2 P P 1 3 2 1 
33 ABBAS C 3 M 1 2 2 3 2 A A 0 1 N A A 3 N N 1 A A A A A 1 1 1 1 A A 1 1 1 1 
34 KRITHIKA C 1 F 1 1 2 1 2 A A 0 3 N P A 1 N N 1 A A A A A 1 1 3 2 P P 1 3 1 1 
35 KANNIKASRI C 2 F 1 2 2 1 2 A A 0 2 N A A 1 N N 1 A A A A A 1 1 3 1 A A 1 3 1 1 
36 SRIRAM C 2 M 2 NA 2 1 1 A A 0 2 Y/P P P 1 N N 1 A A A A A 1 1 3 1 A A 1 3 1 1 
37 MAHESH C 3 M 1 1 1 1 2 A P 1 1 N P A 1 N N 1 Y A A A A 1 1 3 1 A A 2 3 1 1 
38 KISHORE C 1 M 1 2 2 1 2 A A 0 2 N A A 1 N N 1 A A A A A 1 1 3 1 A A 1 3 1 1 
39 KALIYA M 3 M 1 2 2 3 2 A A 0 2 N A A 1 N N 1 A A A A A 1 1 3 1 P A 1 3 1 1 
40 RILWANA T 2 F 1 2 2 3 2 A P 0 2 N A A 1 N N 1 A A A A A 1 1 3 1 P A 1 2 1 1 
41 ARUNKUMAR C 3 M 1 2 2 2 2 A A 0 2 N A A 3 N N 1 A A A A A 1 1 1 1 P A 2 3 2 1 
42 KANNAN C 1 M 1 4 3 1 1 A A 0 1 N NA NA NA NA N 1 A A A A A 1 1 3 2 P A 1 3 1 1 
43 MUTHU KARTHIKA C 3 F 1 2 2 3 2 A A 0 2 N P P 3 N N 1 A A A A A 1 1 2 1 A A 1 3 1 1 
44 AARUMUGAM C 3 M 1 2 2 3 2 A A 0 2 N A A 3 N N 1 A A A A A 1 1 3 1 P P 1 3 1 1 
45 MANIKANDAN C 1 M 1 4 2 1 2 A A 0 2 N NA NA NA NA N 1 A A A A A 1 1 1 1 A A 1 3 1 1 
46 MANEESH K 3 M 1 2 2 3 2 A A 0 2 N P P 1 Y N 1 A A A A A 1 1 2 1 P A 1 3 1 1 
47 LOGESH C 1 M 1 2 2 2 2 A A 0 2 N NA NA 1 N N 1 A A A A A 1 1 3 1 P A 1 3 1 1 
48 NAVANEETH C 2 M 1 2 2 3 1 A A 0 2 N P A 2 N N 1 A A A A A 1 1 3 2 P A 1 3 1 1 
49 VANJINATHAN C 2 M 1 4 1 3 2 A A 0 1 N NA NA 3 N N 1 A A A A A 1 1 3 1 A A 1 3 1 1 
50 JONES VERRONIKA C 2 F 1 2 2 3 2 A P 2 1 N A A 3 N A 1 A A P A A 1 1 3 1 P P 2 3 2 1 
 
  
  
109 
 
S
.
N
o
 
N
a
m
e
 
P
l
a
c
e
 
A
g
e
 
S
e
x
 
breast feeding 
 
diet history 
d
e
v
e
l
o
p
m
e
n
t
a
l
 
m
i
l
e
s
t
o
n
e
s
 
i
m
m
u
n
i
z
a
t
i
o
n
 
h
i
s
t
o
r
y
 
f
a
m
i
l
y
 
h
/
o
 
s
e
i
z
u
r
e
s
 
physical 
examination 
vitals 
  
s
t
a
r
t
e
d
 
a
t
 
d
u
r
a
t
i
o
n
 
w
e
a
n
i
n
g
 
m
i
x
e
d
 
f
e
e
d
s
 
b
i
r
t
h
 
w
e
i
g
h
t
 
H
/
o
 
p
r
o
g
r
e
s
s
i
v
e
 
p
a
l
l
o
r
 
H
/
o
 
f
e
b
r
i
l
e
 
s
e
i
z
u
r
e
 
N
o
 
o
f
 
i
l
l
n
e
s
s
 
i
n
 
l
a
s
t
 
6
 
m
t
h
s
 
o
r
d
e
r
 
o
f
 
b
i
r
t
h
 
h
/
o
 
t
w
i
n
/
 
p
r
e
t
e
r
m
 
p
r
e
g
n
a
n
c
y
 
c
a
l
o
r
i
c
 
g
a
p
 
p
r
o
t
e
i
n
 
g
a
p
 
v
e
g
/
n
o
n
 
v
e
g
 
t
u
b
e
r
s
 
i
n
t
a
k
e
 
p
a
l
l
o
r
 
i
c
t
e
r
u
s
 
d
y
s
m
o
r
p
h
i
s
m
 
s
i
g
n
s
 
o
f
 
 
v
i
t
 
d
e
f
.
 
HR RR RS 
S
e
r
u
m
 
Z
i
n
c
 
1 VIJAYA C 3 F 1 3 1 3 2 A A 0 1 N P P 3 N N 1 A A A A A 2 2 3 1 
2 SRIRAM C 1 M 1 4 3 3 1 A A 0 1 N NA NA 4 N N 1 A A A A A 2 2 3 1 
3 MOHAMMAD HUSSAIN C 1 M 1 4 1 3 2 A A 0 1 N NA NA 2 N N 1 A A A A A 2 2 3 1 
4 VIJAYAKUMARI C 2 F 1 3 1 3 2 A A 0 1 N P P 3 N N 1 A A A A A 2 2 3 1 
5 SUGANYA M 2 F 1 2 1 3 2 A A 0 1 N P P 3 N N 1 A A A A A 2 2 3 1 
6 KALPANA C 1 F 1 4 3 2 2 A A 0 1 N A A 1 N N 1 A A A A A 2 2 3 1 
7 VANITHA C 2 F 1 2 1 3 2 A A 0 1 N A A 3 N N 1 A A A A A 2 2 3 1 
8 VINOD M 2 M 1 2 1 3 2 A A 0 2 N P A 3 N N 1 A A A A A 2 2 3 1 
9 VIYAZ C 2 F 1 2 2 3 2 A A 0 1 N A A 3 N N 1 A A A A A 2 2 3 1 
10 MOHAMMAD ASSAIN C 2 M 1 3 1 3 2 A A 0 1 N A A 3 N N 1 A A A A A 2 2 3 1 
11 PREMA C 1 F 1 4 3 3 2 A A 0 2 N A A 1 N N 1 A A A A A 2 2 3 1 
12 MOHAN C 2 M 1 2 2 1 2 A A 0 2 N A A 1 N N 1 A A A A A 2 2 3 1 
13 HARIHARAN C 3 M 1 2 2 1 1 A P 0 2 N P P 1 N N 1 A A A A A 2 2 3 3 
14 ASHINI C 3 F 1 2 2 3 2 A A 0 2 N P A 3 N N 1 A A A A A 2 2 3 1 
15 GANGADARAN C 2 M 1 2 1 3 2 A A 0 1 N A A 3 N N 1 A A A A A 2 2 3 1 
16 DANVANTH C 2 M 1 2 2 3 2 A A 0 1 N A A 3 N N 1 A A A A A 2 2 3 1 
17 NALINI C 2 F 1 1 1 1 2 A A 0 3 N P P 1 N N 1 A A A A A 2 2 3 2 
18 KALA C 1 F 1 2 2 3 2 A A 0 2 N A A 1 N N 1 A A A A A 2 2 3 1 
19 VANITHA C 3 F 1 1 2 3 2 A A 0 1 N A A 3 N N 1 A A A A A 2 2 3 1 
20 MUTHU C 2 M 1 2 1 2 2 A A 0 1 N A A 3 N N 1 A A A A A 2 2 3 1 
21 MANJU C 3 F 1 2 1 3 2 A A 0 2 N A A 3 N N 1 A A A A A 2 2 3 1 
22 KAVYA C 3 F 1 3 2 2 2 A A 0 1 N A A 3 N N 1 A A A A A 2 2 3 1 
23 NIHARIKA C 3 F 1 3 2 3 2 A A 0 1 N A A 3 N N 1 A A A A A 2 2 3 1 
24 KISHORI C 1 F 1 2 1 2 2 A A 0 1 N A A 3 N N 1 A A A A A 2 2 3 1 
25 SHANTHI C 3 F 1 2 2 3 2 A A 0 1 N A A 3 N N 1 A A A A A 2 2 3 1 
26 JOSUA C 2 M 1 3 2 3 2 A A 0 2 N A A 3 N N 1 A A A A A 2 2 3 1 
27 RAHUL C 2 M 1 3 2 3 2 A A 0 2 N A A 3 N N 1 A A A A A 2 2 3 1 
28 SANTHOSH C 1 M 1 1 2 1 1 A A 0 1 N P A 1 N N 1 A A A A A 2 2 3 3 
29 ANAS C 1 M 1 2 1 3 2 A A 0 1 N A A NA N N 1 A A A A A 2 2 3 1 
30 ANANTHA PADMANASRI C 3 F 1 2 1 3 2 A A 0 1 N A A 3 N N 1 A A A A A 2 2 3 1 
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31 MADHUSRI C 1 F 1 2 1 1 2 A A 0 1 N A A 1 N N 1 A A A A A 2 2 3 1 
32 AFSARA C 2 F 1 2 2 3 2 A A 0 2 N A A 3 N N 1 A A A A A 2 2 3 1 
33 JEEVAN C 3 M 1 3 2 3 2 A A 0 1 N A A 3 A N 1 A A A A A 2 2 3 1 
34 PINKY C 1 F 1 2 3 3 2 A A 0 1 N A A 4 N N 1 A A A A A 2 2 3 1 
35 RANI C 2 F 1 2 1 3 2 A A 0 2 N A A 2 N N 1 A A A A A 2 2 3 2 
36 VIGNESH C 2 M 1 2 2 3 2 A A 0 1 N A A 3 N N 1 A A A A A 2 2 3 1 
37 MURUGAN C 3 M 1 2 2 1 2 A A 0 1 N A A 1 N N 1 A A A A A 2 2 3 3 
38 ALTHAF C 1 M 1 2 1 3 2 A A 0 2 N A A 1 N N 1 A A A A A 2 2 3 2 
39 KAVYAN C 3 M 1 2 2 3 2 A A 0 3 N A A 1 N N 1 A A A A A 2 2 3 3 
40 ARUNA C 2 F 1 2 1 3 2 A A 0 1 N A A 3 N N 1 A A A A A 2 2 3 1 
41 SARAVANAN C 3 M 1 2 1 3 2 A A 0 2 N P P 1 N N 1 A A A A A 2 2 3 2 
42 MAHESWARAN C 1 M 1 4 2 1 2 A A 0 1 N NA NA 1 N N 1 A A A A A 2 2 3 3 
43 SHIFANA C 3 F 1 2 2 3 2 A A 0 1 N A A 3 N N 1 A A A A A 2 2 3 1 
44 LINGESH C 3 M 1 2 2 1 2 A A 0 1 N P P 3 N N 1 A A A A A 2 2 3 2 
45 BALAMURUGAN C 1 N 1 4 3 3 2 A A 0 1 N NA NA NA N N 1 A A A A A 2 2 3 1 
56 RAVI C 3 M 1 3 2 3 2 A A 0 2 N P A 3 N N 1 A A A A A 2 2 3 1 
47 RAMESH C 1 M 1 4 1 3 2 A A 0 1 N NA NA 2 N N 1 A A A A A 2 2 3 1 
48 SARVESH C 2 M 1 2 1 3 2 A A 0 1 N A A 3 N N 1 A A A A A 2 2 3 1 
49 ROSHAN C 2 M 1 4 1 3 2 A A 0 1 N NA NA 3 N N 1 A A A A A 2 2 3 1 
50 MAHESWARI C 2 F 1 2 2 3 2 A A 0 1 N A A 3 N N 1 A A A A A 2 2 3 1 
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KEY TO MASTER CHART 
Age 
< 1 yr 1 
1 -2 yr 2 
>2 -5 yr 3 
Breast feeding  duration   WEANING 
Started at birth 1            < 6 mon 1  > 6 mon 1 
Not started 2  6 mon – 1 yr 2  < 6 mo  2 
    >1 yr  3  not yet/NA 3 
    Till date/NA 4 
MIXED FEEDS 
COWS MILK  1 
FORMULA MILK 2 
NIL   3 
BOTH   4 
BIRTH WEIGHT 
<2.5 KG  1 
2.5 KG  2 
PROGRESSIVE PALLOR  PRESENT/ ABSENT 
FEBRILE  SEIZURE   PRESENT / ABSENT 
NO OF ILLNESS LAST 6 MON 0,1,2, 
REGULAR AN VISITS  YES/NO 
BIRTH ORDER   1-1, 2-2, >3 – 3 
H/O PRETERM , TWIN  Y/N 
DIET HISTORY 
CALORIE GAP PRESENT/ABSENT/NA 
PROTEIN GAP PRESENT/ABSENT/NA 
VEG  1 
EGG ONLY 2 
NON VEG 3 
NA  4 
H/O INTAKE OF TUBERS  
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2 TIMES A WEEK Y/N 
DEVELOPMENTAL MILESTONES  NORMAL/ABNORMAL 
IMMUNISATION UPTODATE    1 
   PARTIALLY IMMUNISED  2 
FAMILY H/O SEIZURE PRESENT /ABSENT 
DYSMORPHOLOGY PRESENT/ABSENT 
PALLOR   PRESENT/ABSENT 
ICTERUS   PRESENT/ABSENT 
HEART RATE  RESPIRATORY RATE  SPO2 
TACHYCARDIA 1  TACHYPNEA 1   >92% 1 
NORMAL 2  NORMAL 2   <92% 2  
         <90%  3 
RESPIRATORY SYSTEM 
SUBCOSTAL /INTERCOSTAL RETRACTION 1 
SUPRA STERNAL RETRACTION    2 
NORMAL      3 
 
COMPLETE BLOOD COUNT 
LEUCOCYTOSIS  PRESENT/ABSENT 
ANEMIA   PRESENT /ABSENT 
CHEST X RAY 
BRONCHO PNEUMONIA  1 
CONSOLIDATION   2 
SERUM ZINC LEVEL 
>65 mcg  1 
50 – 64 mcg  2 
<50 mcg  3 
HOSPITAL STAY 
<7 DAYS  1 
>7 DAYS   2 
OUTCOME 
DISCHARGE  1 
DEATH  2  
